Circulating matrix metalloproteinase-8 (MMP-8) and MMP-9 are increased in chronic periodontal disease and decrease after non-surgical periodontal therapy

• Published in: Clinica chimica acta Vol. 409; no. 1; pp. 117 - 122
• Main Authors: Marcaccini, Andrea M., Novaes, Arthur B., Meschiari, Cesar A., Souza, Sergio L., Palioto, Daniela B., Sorgi, Carlos A., Faccioli, Lucia H., Tanus-Santos, Jose E., Gerlach, Raquel F.
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 01.11.2009
• Subjects: Adult; Case-Control Studies; Chronic Disease; Female; Gelatin - metabolism; Gelatinolytic activity; Humans; Matrix metalloproteinase; Matrix Metalloproteinase 8 - blood; Matrix Metalloproteinase 8 - metabolism; Matrix Metalloproteinase 9 - blood; Matrix Metalloproteinase 9 - metabolism; Middle Aged; Non-surgical therapy; Periodontal Diseases - blood; Periodontal Diseases - metabolism; Periodontal Diseases - surgery; Periodontal Diseases - therapy; Periodontitis; Systemic inflammation; Tissue Inhibitor of Metalloproteinase-1 - blood; Tissue Inhibitor of Metalloproteinase-1 - metabolism; Tissue Inhibitor of Metalloproteinase-2 - blood; Tissue Inhibitor of Metalloproteinase-2 - metabolism; Gelatinolytic activity; Matrix metalloproteinase; Periodontitis; Systemic inflammation; Non-surgical therapy
• ISSN: 0009-8981; 1873-3492
• DOI: 10.1016/j.cca.2009.09.012

Periodontal disease shares risk factors with cardiovascular diseases and other systemic inflammatory diseases. The present study was designed to assess the circulating matrix metalloproteinases (MMPs) from chronic periodontal disease patients and, subsequently, after periodontal therapy. We compared the plasma concentrations of MMP-2, MMP-3, MMP-8, MMP-9, tissue inhibitor of metalloproteinase-1 (TIMP-1) and TIMP-2, and total gelatinolytic activity in patients with periodontal disease ( n = 28) with those of control subjects ( n = 22) before and 3 months after non-surgical periodontal therapy. Higher plasma MMP-3, MMP-8, and MMP-9 concentrations were found in periodontal disease patients compared with healthy controls (all P < 0.05), whereas MMP-2, TIMP-1, and TIMP-2 levels were not different. Treatment decreased plasma MMP-8 and MMP-9 concentrations by 35% and 39%, respectively (both P < 0.02), while no changes were found in controls. MMP-2, MMP-3, TIMP-1, and TIMP-2 remained unaltered in both groups. Plasma gelatinolytic activity was higher in periodontal disease patients compared with controls ( P < 0.001) and decreased after periodontal therapy ( P < 0.05). This study showed increased circulating MMP-8 and MMP-9 levels and proteolytic activity in periodontal disease patients that decrease after periodontal therapy. The effects of periodontal therapy suggest that it may attenuate inflammatory chronic diseases.